Biomaterials Group, Department of Nanotechnology & Advanced Materials, Materials and Energy Research Center, Karaj, Iran.
Biomaterials Group, Department of Nanotechnology & Advanced Materials, Materials and Energy Research Center, Karaj, Iran.
Mater Sci Eng C Mater Biol Appl. 2019 May;98:227-240. doi: 10.1016/j.msec.2018.12.129. Epub 2018 Dec 29.
The aim of this study was to find an optimum dose of the synthetic amorphous calcium phosphate (ACP) nanoparticles to be incorporated in resin-modified glass ionomer cements (RMGICs) for triggering the release of PO/Ca, alkaline phosphatase (ALP) activity and osteogenic differentiation of mesenchymal stem cells (hMSCs) without significantly affecting the essential properties of the cements. RMGICs were formulated from the powder composed of melt-derived strontium fluoro-aluminosilicate glass (SFAG) and synthetic ACP nanoparticles (0-20 wt%), as well as commercial polyalkenoic acid liquid. The effect of ACP incorporation on the workability, microstructure, Ca/PO/F ion release and compressive strength was investigated. The response of hMSCs to the optimized cements was assessed by MTT cytotoxicity, ALP activity, and staining tests. The working time of the formulated RMGICs decreased significantly upon increase of ACP content from 5 to 20%. ACP (5%)-incorporated RMGICs showed improved photopolymerization and setting. An insignificant reduction was recorded in the compressive strength of RMGICs with addition of 1.5-5% ACP. The fluoride release didn't significantly decrease due to addition of 5% ACP. Upon incorporating 5% ACP, the biocompatibility of RMGICs rose to about 20%. In addition, ALP activity and osteogenic differentiation of hMSCs noticeably increased after exposure to ACP-incorporated RMGIC. ACP (5%)-incorporated RMGICs could be promising candidates for both restorative and regenerative dentistry owing to the optimum mechanical strength, prolonged ion release, and their effective role in the cell differentiation and biomineralization demanded for pulp regeneration.
本研究旨在寻找一种最佳剂量的合成无定形磷酸钙 (ACP) 纳米颗粒,将其掺入树脂改性玻璃离子水门汀 (RMGIC) 中,以触发 PO/Ca、碱性磷酸酶 (ALP) 活性和间充质干细胞 (hMSC) 的成骨分化,而不会显著影响水门汀的基本性能。RMGIC 由熔融衍生的锶氟铝硅酸盐玻璃 (SFAG) 和合成 ACP 纳米颗粒 (0-20wt%) 以及商业聚烯酸液体组成的粉末制成。研究了 ACP 掺入对工作性、微观结构、Ca/PO/F 离子释放和抗压强度的影响。通过 MTT 细胞毒性、ALP 活性和染色试验评估 hMSC 对优化后的水门汀的反应。随着 ACP 含量从 5%增加到 20%,所配制的 RMGIC 的工作时间显著降低。ACP(5%)掺入的 RMGIC 显示出更好的光聚合和凝固。添加 1.5-5%的 ACP 时,RMGIC 的抗压强度记录到了轻微的下降。由于添加了 5%的 ACP,氟化物的释放并没有明显减少。当掺入 5%的 ACP 时,RMGIC 的生物相容性上升到约 20%。此外,hMSC 的 ALP 活性和成骨分化在暴露于 ACP 掺入的 RMGIC 后明显增加。由于具有最佳的机械强度、延长的离子释放以及在牙髓再生所需的细胞分化和生物矿化方面的有效作用,ACP(5%)掺入的 RMGIC 有望成为修复和再生牙科的候选材料。